Denali Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US24823R1059
USD
20.25
5.61 (38.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryDenali Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
38.27%
0.03%
1W
45.37%
-0.35%
1M
40.92%
0.08%
YTD
-0.64%
1.02%
1Y
-3.66%
13.02%
3Y
-10.32%
72.04%
5Y
-21.3%
80.03%
10Y
-21.3%
262.66%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
35.45%
0%
35.45%
6 Months
-17.31%
0%
-17.31%
1 Year
-3.66%
0%
-3.66%
2 Years
-33.65%
0%
-33.65%
3 Years
-10.32%
0%
-10.32%
4 Years
-72.71%
0%
-72.71%
5 Years
-21.3%
0%
-21.3%

Denali Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary